Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01293474

Choroidal Thickness in Glaucoma Patients and Healthy Controls

Glaucoma Patients and Healthy Controls Clinical Trial

Clinical Trial Summary

With the new software tool (EDI, enhanced depth imaging) of the Spectralis® spectral-domain optical coherence tomography (SD-OCT) it is possible to visualize and measure the choroidal thickness. In glaucoma a vascular component is known. Therefore a difference of choroidal thickness in glaucoma patients and healthy controls is proposed.

- Trial with medical device

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

  • Glaucoma
  • Glaucoma Patients and Healthy Controls
Clinical Trial Details
NCT number NCT01293474
Study type Observational
Source University of Zurich
Contact
Status Enrolling by invitation
Phase Phase 4
Start date February 2011
Completion date December 2015
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT01299233 - Reproducibility of RNFL Circle Scans With ART-Function of Heidelberg Spectralis SD-OCT Software Version 5.3 Phase 4
Terminated NCT01273285 - Reproducibility of Nerve Fiber Layer Thickness Measurements in Patients With Glaucoma and Healthy Controls Using Spectral-Domain and Time-Domain OCT Phase 4